ArticleJournal of laboratory physicians
Phenotypic and genotypic characterization of carbapenem resistance mechanisms in
Article in Journal of laboratory physicians. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 10 citations in OpenAlex.
- An Overview of Virulence, Resistance, and Clinical Significance of Klebsiella Infections.Cureus · 2026Review
- Prevalence and Molecular Characterization of Carbapenemase and Hypervirulence Genes inInternational journal of microbiology · 2026Article
- Phenotypic and genotypic analysis of hypermucoviscousIranian journal of microbiology · 2025Article
- Temporal Shifts in Etiological Agents and Trends in Antimicrobial Resistance of Bloodstream Infection in Southwest China from 2016 to 2023.Infection and drug resistance · 2025Article
- Evaluation of biofilm formation and carbapenem resistance inJournal of family medicine and primary care · 2024Article
- Association between Presence ofIranian journal of public health · 2021Article
- Genomic Analysis of Antimicrobial Resistance and Resistance Plasmids inAntibiotics (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEmergence of carbapenem resistance among MATERIALS AND
methods50 non-duplicate carbapenem resistant isolates of
resultsOut of 50 isolates, 39 (78%) of
conclusionsCarbapenems are often considered last resort antibiotics in the treatment of infections due to multidrug-resistant organisms. It is therefore mandatory to maintain the clinical efficacy of carbapenems by early detection of various enzymes. For routine clinical laboratories both phenotypic and genotypic tests need to be followed to detect various mechanisms of carbapenem resistance and this is of epidemiological relevance also.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.